UBS Group’s Zosano Pharma Corporation ZSAN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-4,133
| Closed | -$32K | – | 10474 |
|
2022
Q1 | $32K | Buy |
4,133
+1,993
| +93% | +$15.4K | ﹤0.01% | 5917 |
|
2021
Q4 | $35K | Buy |
2,140
+1,863
| +673% | +$30.5K | ﹤0.01% | 6144 |
|
2021
Q3 | $7K | Sell |
277
-19
| -6% | -$480 | ﹤0.01% | 7234 |
|
2021
Q2 | $10K | Sell |
296
-228
| -44% | -$7.7K | ﹤0.01% | 6997 |
|
2021
Q1 | $23K | Sell |
524
-272
| -34% | -$11.9K | ﹤0.01% | 6250 |
|
2020
Q4 | $14K | Sell |
796
-2,975
| -79% | -$52.3K | ﹤0.01% | 6227 |
|
2020
Q3 | $214K | Buy |
3,771
+1,880
| +99% | +$107K | ﹤0.01% | 3951 |
|
2020
Q2 | $57K | Sell |
1,891
-964
| -34% | -$29.1K | ﹤0.01% | 4919 |
|
2020
Q1 | $56K | Buy |
2,855
+896
| +46% | +$17.6K | ﹤0.01% | 4872 |
|
2019
Q4 | $105K | Buy |
1,959
+945
| +93% | +$50.7K | ﹤0.01% | 4949 |
|
2019
Q3 | $55K | Sell |
1,014
-532
| -34% | -$28.9K | ﹤0.01% | 5216 |
|
2019
Q2 | $177K | Buy |
1,546
+760
| +97% | +$87K | ﹤0.01% | 4175 |
|
2019
Q1 | $131K | Buy |
786
+572
| +267% | +$95.3K | ﹤0.01% | 4113 |
|
2018
Q4 | $16K | Buy |
214
+91
| +74% | +$6.8K | ﹤0.01% | 6044 |
|
2018
Q3 | $17K | Buy |
+123
| New | +$17K | ﹤0.01% | 5983 |
|
2018
Q2 | – | Sell |
-7
| Closed | -$1K | – | 7241 |
|
2018
Q1 | $1K | Sell |
7
-13
| -65% | -$1.86K | ﹤0.01% | 6786 |
|
2017
Q4 | $7K | Buy |
20
+16
| +400% | +$5.6K | ﹤0.01% | 6284 |
|
2017
Q3 | $2K | Hold |
4
| – | – | ﹤0.01% | 6584 |
|
2017
Q2 | $4K | Buy |
4
+2
| +100% | +$2K | ﹤0.01% | 6285 |
|
2017
Q1 | $3K | Buy |
+2
| New | +$3K | ﹤0.01% | 6287 |
|
2016
Q2 | – | Hold |
0
| – | -$1K | – | 6990 |
|
2016
Q1 | – | Sell |
-1
| Closed | -$2K | – | 6592 |
|
2015
Q4 | $2K | Buy |
+1
| New | +$2K | ﹤0.01% | 6618 |
|
2015
Q3 | – | Sell |
-1
| Closed | -$6K | – | 7014 |
|
2015
Q2 | $6K | Hold |
1
| – | – | ﹤0.01% | 6233 |
|
2015
Q1 | $9K | Buy |
+1
| New | +$9K | ﹤0.01% | 5938 |
|